4-127804033-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014278.4(HSPA4L):c.931G>A(p.Ala311Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000836 in 1,614,052 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.00048 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000042 ( 0 hom. )
Consequence
HSPA4L
NM_014278.4 missense
NM_014278.4 missense
Scores
5
14
Clinical Significance
Conservation
PhyloP100: 4.90
Genes affected
HSPA4L (HGNC:17041): (heat shock protein family A (Hsp70) member 4 like) The protein encoded by this gene is heat shock inducible and may act as a chaperone. The encoded protein can protect the heat-shocked cell against the harmful effects of aggregated proteins. This gene is highly expressed in leukemia cells and may be a good target for therapeutic intervention. Several transcripts encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.037582546).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HSPA4L | NM_014278.4 | c.931G>A | p.Ala311Thr | missense_variant | 8/19 | ENST00000296464.9 | NP_055093.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HSPA4L | ENST00000296464.9 | c.931G>A | p.Ala311Thr | missense_variant | 8/19 | 1 | NM_014278.4 | ENSP00000296464.3 | ||
HSPA4L | ENST00000508549.5 | c.808G>A | p.Ala270Thr | missense_variant | 7/13 | 1 | ENSP00000427305.1 | |||
HSPA4L | ENST00000508776.5 | c.931G>A | p.Ala311Thr | missense_variant | 9/20 | 2 | ENSP00000422482.1 | |||
HSPA4L | ENST00000505726.1 | c.853G>A | p.Ala285Thr | missense_variant | 8/19 | 2 | ENSP00000425645.1 |
Frequencies
GnomAD3 genomes AF: 0.000480 AC: 73AN: 152174Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
73
AN:
152174
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000995 AC: 25AN: 251238Hom.: 0 AF XY: 0.0000663 AC XY: 9AN XY: 135784
GnomAD3 exomes
AF:
AC:
25
AN:
251238
Hom.:
AF XY:
AC XY:
9
AN XY:
135784
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000424 AC: 62AN: 1461760Hom.: 0 Cov.: 31 AF XY: 0.0000344 AC XY: 25AN XY: 727182
GnomAD4 exome
AF:
AC:
62
AN:
1461760
Hom.:
Cov.:
31
AF XY:
AC XY:
25
AN XY:
727182
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000479 AC: 73AN: 152292Hom.: 0 Cov.: 32 AF XY: 0.000416 AC XY: 31AN XY: 74454
GnomAD4 genome
AF:
AC:
73
AN:
152292
Hom.:
Cov.:
32
AF XY:
AC XY:
31
AN XY:
74454
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
6
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
16
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 13, 2024 | The c.931G>A (p.A311T) alteration is located in exon 8 (coding exon 8) of the HSPA4L gene. This alteration results from a G to A substitution at nucleotide position 931, causing the alanine (A) at amino acid position 311 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D;D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;.;.
PrimateAI
Benign
T
PROVEAN
Uncertain
N;N;D;D
REVEL
Benign
Sift
Benign
D;D;T;D
Sift4G
Benign
T;T;T;T
Polyphen
B;B;.;B
Vest4
MVP
MPC
0.20
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at